S. Rouan
Förmögenhet: 40 424 $ per 2026-09-30
Förmögenhet: 40 424 $ per 2026-09-30
S.
Kathryn Rouan is currently Non-Executive Director at Code Biotherapeutics, Inc. and Independent Director at Viking Therapeutics, Inc. since 2019.
Former roles include Chairman at Navidea Biopharmaceuticals, Inc. from 2018 to 2021, Senior VP, Head-Research & Development at Stiefel Laboratories, Inc. from 2013 to 2016, SVP, Head-Projects, Clinical Platforms & Sciences at GlaxoSmithKline LLC from 2016 to 2018, and Vice President at GlaxoSmithKline LLC from 2003 to 2013.
Education includes a doctorate from the University of Rhode Island.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-15 | 1 240 ( 0 % ) | 40 424 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2019-07-01 |
Code Biotherapeutics, Inc.
Code Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Ordförande | 2021-09-14 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Företagsledare/Principal | 2018-12-01 |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | 2016-05-01 |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Företagsledare/Principal | 2013-12-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes precision diagnostics and radiopharmaceutical agents | Health Technology |
University of Rhode Island
University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Viking Therapeutics, Inc.
Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
Code Biotherapeutics, Inc.
Code Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån